Edoxaban Dose Reduction Criteria

Apply edoxaban dose reduction criteria for VTE treatment (60 mg to 30 mg daily) and AF: CrCl 15–50 mL/min, body weight ≤60 kg, or concomitant P-gp inhibitors. Unique: better at higher CrCl than lower.

Weight
Height
Clinical Guidance

BMI is a screening measure of body size, not a direct measure of body fat. The standard WHO categories are underweight (<18.5), normal (18.5–24.9), overweight (25–29.9), and obese (≥30).

BMI can overestimate body fat in athletes with high muscle mass and underestimate it in older adults with low muscle mass. Interpret it alongside waist circumference and clinical context rather than as a standalone diagnosis.

⚕ Clinical Disclaimer: These calculators are for educational and reference purposes only. Always verify results with qualified clinical judgment and current clinical guidelines. Do not use as a sole basis for medical decisions.
Advertisement

How to Use

Enter the values for the scenario you are assessing. Apply edoxaban dose reduction criteria for VTE treatment (60 mg to 30 mg daily) and AF: CrCl 15–50 mL/min, body weight ≤60 kg, or concomitant P-gp inhibitors. Unique: better at higher CrCl than lower. Use the edoxaban dose reduction result to inform your calculation.

Related Calculators

Rivaroxaban Renal Dose

Medical Long-tail

Creatinine Clearance

Medical

Frequently Asked Questions